|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0028 | ED148961 | General Research Use | No | Female | White | 65 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0517 | ED148396 | General Research Use | No | Female | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0612 | ED149145 | General Research Use | No | Male | White | 69 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0942 | ED149546 | General Research Use | No | Male | White | 68 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0953 | ED148468 | General Research Use | No | Female | White | 65 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0994 | ED148494 | General Research Use | No | Female | White | 67 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1059 | ED149372 | General Research Use | No | Female | Black or African American | 66 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_1172 | ED149249 | General Research Use | No | Female | White | 69 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1660 | ED149484 | General Research Use | No | Female | White | 68 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1918 | ED148164 | General Research Use | No | Female | White | 67 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2926 | ED148443 | General Research Use | No | Male | White | 66 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2968 | ED149203 | Eye Disease Only | No | Female | White | 68 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3072 | ED149698 | General Research Use | No | Male | White | 65 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3638 | ED148988 | General Research Use | No | Male | White | 67 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3702 | ED149283 | Eye Disease Only | No | Female | White | 66 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_3704 | ED149951 | General Research Use | No | Female | White | 66 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3717 | ED148079 | General Research Use | No | Female | White | 68 | 9 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_4234 | ED148104 | General Research Use | Yes | Female | White | 67 | | |
| AR2_0286 | ED149189 | General Research Use | No | Male | White | 69 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0390 | ED148833 | General Research Use | No | Female | White | 66 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |